PROFOUND MEDICAL CORP. (PROF)

6.85 -1.58% (-0.11)

Over 3Y: -15.1%

2026-08-28
Style
Area Line Line with markersneeds a shorter window Steps Candlesneeds a shorter window Hollow candlesneeds a shorter window Barsneeds a shorter window

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

5 7.5 10
2023 2024 2025 2026

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q1 '24 — Revenue: 1.4M Q1 '24 — Operating Cash Flow: -4.5M Q2 '24 — Revenue: 2.2M Q2 '24 — Operating Cash Flow: -6.2M Q3 '24 — Revenue: 2.8M Q3 '24 — Operating Cash Flow: -6.8M Q4 '24 — Revenue: 4.2M Q4 '24 — Operating Cash Flow: -5.9M Q1 '25 — Revenue: 2.6M Q1 '25 — Operating Cash Flow: -8.3M Q2 '25 — Revenue: 2.2M Q2 '25 — Operating Cash Flow: -13.7M Q3 '25 — Revenue: 5.3M Q3 '25 — Operating Cash Flow: -9.6M Q4 '25 — Revenue: 6M Q4 '25 — Operating Cash Flow: -6.6M Q1 '26 — Revenue: 5.3M Q1 '26 — Operating Cash Flow: -8.6M Q2 '26 — Revenue: 2.5M Q2 '26 — Operating Cash Flow: -11.3M -12M -8M -4M 0 4M 8M
Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.6
SBC / sales 26.1%
OE margin -216.1%
Oper. margin -185.3%
ROIC -136.0%
Gross margin 71.8%
Accruals 5.4%
EBITDA margin -183.4%
FCF margin -190.1%
OCF margin -189.1%
Profit margin -171.6%
ROA -52.5%
ROCE -66.4%
ROE -65.7%
OCF / EBIT —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

2.0
RPO / sales 0.018×
RPO growth —
Segment HHI —

4 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.5
ND/EBITDA —
Interest cover -97.4×
Cash / Debt 4.2×
Debt payback 0.0 yr
Quick ratio 5.3×
Debt / Eq 0.18×
Cash runway 0.81 yr
F-score 4.0 pts
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

7.0
Sales/sh Y/Y +32.0%
Sales CAGR 4Y +25.7%
Sales Q/Q +12.3%
Shares change +22.1%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.